BEECH-NUT, INC. – Trademark Portfolio
Entity Type: 03
BEECH-NUT, INC. owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as BUSTELO, BREATH SAVER, and BREATH SAVERS. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 30 (Staple Foods) and Class 5 (Pharmaceuticals). Headquartered in NEW YORK, NY.
40 W. 57TH ST.
NEW YORK, NY 10019
Showing of trademarks Trademarks
Trademark Classifications
BEECH-NUT, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BEECH-NUT, INC. have?
BEECH-NUT, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 10 cancelled.
What trademark classes does BEECH-NUT, INC. file in?
BEECH-NUT, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 3 (Cosmetics & Cleaning). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are BEECH-NUT, INC.'s most well-known trademarks?
BEECH-NUT, INC.'s registered trademark portfolio includes well-known marks such as BUSTELO, BREATH SAVER, and BREATH SAVERS. These are among 3 currently registered trademarks in the portfolio.
What is BEECH-NUT, INC.'s trademark registration success rate?
BEECH-NUT, INC. has a 23% trademark registration rate, with 3 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.